Figure 3: Impact of GLC and GLC Receptor Antagonist on Cardiac Hypertrophy in Post-Myocardial Infarct Heart
2019-06-11T07:01:25Z (GMT) by
(A) Heart weight (HW) versus body weight (BW) 4 weeks after MI treated with PBS (Control), GLC, and GLC receptor antagonist (REMD). Groups sizes are indicated. (B) Myocyte cross-sectional areas (CSA) in left ventricles of the same mouse groups as in pane A. Group sizes are indicated. ## p< 0.001, #p < 0.01, *p < 0.05. Abbreviations as in Figure 1.